triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial ⭐️topline results from TRIUMPH-1, 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Dual and Triple Gut Peptide

Cancer Medicine , 5 , 3489

Patient reports from real-world use, including online forums and reviews, occasionally mention back pain

NTBI is highly redox-active and is a primary driver of oxidative stress

GHK-Cu (systemic) Already covered in healing section, but worth noting for skin: Improves skin quality throughout body Hair growth and thickness Anti-aging effects Better results than topical for some people Melanotan I (Afamelanotide) Primary uses: Tanning without sun exposure Protection against UV damage Erythropoietic protoporphyria treatment Typical dosing: 0.5-1mg daily until desired tan achieved Then 0.5-1mg 2-3x weekly for maintenance Administration: Subcutaneous injection Special notes: Safer than Melanotan II (no libido/nausea effects) FDA-approved for EPP (rare condition) Causes gradual tanning Permanent skin darkening with continued use Specialty and niche peptides Less common but valuable for specific purposes

However, no evidence of clinical implications of TMAO in the central nervous system has been documented as yet, but TMAO is present at detectable levels in the cerebro-spinal fluid (CSF)